These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19911951)

  • 21. Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam.
    Li F; Song S; Guo Y; Zhao Q; Zhang X; Pan W; Yang X
    Drug Deliv; 2015; 22(4):487-98. PubMed ID: 24524289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro permeation studies of nanoemulsions containing ketoprofen as a model drug.
    Kim BS; Won M; Lee KM; Kim CS
    Drug Deliv; 2008 Sep; 15(7):465-9. PubMed ID: 18712624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: In vitro and in vivo evaluation.
    Inugala S; Eedara BB; Sunkavalli S; Dhurke R; Kandadi P; Jukanti R; Bandari S
    Eur J Pharm Sci; 2015 Jul; 74():1-10. PubMed ID: 25845633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin nanoemulsion for transdermal application: formulation and evaluation.
    Rachmawati H; Budiputra DK; Mauludin R
    Drug Dev Ind Pharm; 2015 Apr; 41(4):560-6. PubMed ID: 24502271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cremophor RH40-PEG 400 microemulsions as transdermal drug delivery carrier for ketoprofen.
    Ngawhirunpat T; Worachun N; Opanasopit P; Rojanarata T; Panomsuk S
    Pharm Dev Technol; 2013; 18(4):798-803. PubMed ID: 22023398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis.
    Conaghan PG; Dickson J; Bolten W; Cevc G; Rother M
    Rheumatology (Oxford); 2013 Jul; 52(7):1303-12. PubMed ID: 23542612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of meloxicam formulations utilizing ternary complexation for solubility enhancement.
    Awasthi SS; Kumar TG; Manisha P; Preeti Y; Kumar SS
    Pak J Pharm Sci; 2011 Oct; 24(4):533-8. PubMed ID: 21959817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fabrication, Characterization, In vitro Evaluation of Solid Lipid Nanoemulsion of Flunarizine dihydrochloride for Nasal Delivery.
    Newton MJ; Harjot K
    Antiinflamm Antiallergy Agents Med Chem; 2017; 15(3):204-220. PubMed ID: 27993106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transdermal delivery of ketoprofen using microemulsions.
    Rhee YS; Choi JG; Park ES; Chi SC
    Int J Pharm; 2001 Oct; 228(1-2):161-70. PubMed ID: 11576778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer.
    Patel MM; Amin AF
    Drug Deliv; 2011 May; 18(4):281-93. PubMed ID: 21138335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoemulsion: for improved oral delivery of repaglinide.
    Akhtar J; Siddiqui HH; Fareed S; Badruddeen ; Khalid M; Aqil M
    Drug Deliv; 2016 Jul; 23(6):2026-34. PubMed ID: 27187792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential.
    Singh B; Khurana L; Bandyopadhyay S; Kapil R; Katare OO
    Drug Deliv; 2011 Nov; 18(8):599-612. PubMed ID: 22008038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surfactant-Assisted Wet Granulation-Based Matrix Tablets without Exceptional Additives: Prolonging Systemic Exposure of Model BCS Class II Ketoprofen.
    Shamim R; Shafique S; Hussain K; Abbas N; Ijaz S; Bukhari NI
    AAPS PharmSciTech; 2024 Oct; 25(7):241. PubMed ID: 39402222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. pH-sensitive nanoparticles of curcumin-celecoxib combination: evaluating drug synergy in ulcerative colitis model.
    Gugulothu D; Kulkarni A; Patravale V; Dandekar P
    J Pharm Sci; 2014 Feb; 103(2):687-96. PubMed ID: 24375287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New celecoxib multiparticulate systems to improve glioblastoma treatment.
    Vera M; Barcia E; Negro S; Marcianes P; García-García L; Slowing K; Fernández-Carballido A
    Int J Pharm; 2014 Oct; 473(1-2):518-27. PubMed ID: 25066075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and evaluation of fast-dissolving tablets of meloxicam-β-cyclodextrin complex prepared by direct compression.
    Obaidat AA; Obaidat RM
    Acta Pharm; 2011 Mar; 61(1):83-91. PubMed ID: 21406346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe.
    Bali V; Ali M; Ali J
    Colloids Surf B Biointerfaces; 2010 Apr; 76(2):410-20. PubMed ID: 20042320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization.
    Ah YC; Choi JK; Choi YK; Ki HM; Bae JH
    Int J Pharm; 2010 Jan; 385(1-2):12-9. PubMed ID: 19833177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
    Cirri M; Mura P; Mora PC
    Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential of nanoemulsions for intravenous delivery of rifampicin.
    Ahmed M; Ramadan W; Rambhu D; Shakeel F
    Pharmazie; 2008 Nov; 63(11):806-11. PubMed ID: 19069240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.